Skip to content

Determination of ED50 and BIS50 in elderly patients with remidazolam toluene sulfonate induction and its efficacy and safety in anesthesia induction for elective surgery

Efficacy and safety of remazolam toluenesulfonate for anesthesia induction in elderly patients undergoing elective surgery: a randomized, single blind, positive drug parallel controlled study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046482
Enrollment
Unknown
Registered
2021-05-16
Start date
2021-05-17
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective surgery

Interventions

Intervention Group:I.V. Remazolam toluenesulfonate 0.05mg/kg
Control Group:I.V. Eomidate 0.05mg/kg

Sponsors

Department of Anesthesiology, Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
61 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 65-85 years old, regardless of gender; 2. The patients underwent elective surgery (endotracheal intubation / laryngeal mask airway mechanical ventilation); 3. The ASA score was grade I ~ III (Annex 4); 4. 18 kg/m2<BMI<30kg/m2; 5. They clearly understood and voluntarily participated in the study, and their informed consent was signed by themselves.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; hypovolemia, shock or coma; 2. Besides general intravenous anesthesia, other anesthesia methods should be combined, such as inhalation anesthesia, epidural anesthesia, subarachnoid anesthesia, etc; 3. Infectious heart disease such as myocarditis or endocarditis; 4. We plan to perform cardiopulmonary bypass; plan heart, liver, kidney transplantation; plan the type of operation may affect the collection of BIS index; 5. Coagulation function was abnormal (Pt or INR >= 1.5 x ULN, APTT >= 1.5 x ULN); 6. Anemia or thrombocytopenia, Hb = 2.5 x ULN, TBIL >= 1.5 x ULN; 8. Renal function was abnormal, urea or urea nitrogen >= 1.5 x ULN, and serum creatinine was higher than the upper limit of normal value; 9. Acute heart failure; unstable angina pectoris; myocardial infarction within 6 months before screening; resting ECG heart rate = 450 ms, female >= 470 MS; 10. Patients with hypertension whose blood pressure was not controlled satisfactorily (SBP >= 160 mmHg and / or DBP >= 100 mmHg during screening period); 11. During the screening period, the sitting systolic blood pressure was <= 90 mmHg; 12. 1 mmol / L in the screening period; 13. There was a history of drug abuse and / or alcohol abuse within 2 years before screening, i.e. drinking more than 2 units of alcohol per day (1 unit = 360 ml beer or 45 ml liquor with 40% alcohol content or 150 ml wine); 14. Patients with mental system diseases (schizophrenia, mania, bipolar disorder, mental disorder, etc.) and long-term use of psychotropic drugs and cognitive dysfunction; 15. Allergic or contraindicated to benzodiazepines, opioids, etomidate, muscle relaxants and their components; 16. Patients with respiratory tract management difficulties (e.g. modified Markovian score grade IV); 17. Participated in other drug clinical trials as subjects in recent 3 months; 18. Other situations in which the researchers consider it inappropriate to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Success rate of anesthesia induction;

Secondary

MeasureTime frame
Incidence of delirium in postoperative recovery period;The incidence of delirium within 3 days after operation;Incidence of adverse reactions;D50 of remazolam toluenesulfonate for induction of general anesthesia in elderly patients;BIS value (bis50) of remazolam toluenesulfonate used in inducing half of elderly patients to fall asleep under general anesthesia;IL-6;

Countries

China

Contacts

Public ContactWang Tianlong

Xuanwu Hospital Capital Medical University

w_tl5595@hotmail.com+86 13910525304

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026